Diabetes Drug Gets FDA Warning Due to Amputation Risk

WEDNESDAY, May 17, 2017 (HealthDay News) The type 2 diabetes prescription drug canagliflozin (brand names Invokana, Invokamet, Invokamet XR) appears to increase the risk of leg and foot amputations, the U.S. Food and Drug Administration now says. The FDA is requiring the medications to carry new...

By: zoolligakampung

You're now about to leave Blogged.my to an external website. We are not responsible for the content of external websites. We do not produce them or maintain/update them; we cannot change them and the content can be changed without our knowledge or agreement.

By proceeding to the external website, you agree that all user generated content submitted to our website are the responsibility of the user alone, and should not be understood to be our endorsement of that website or the site's owners (or their content/products/services).

We'll be redirecting you shortly... click here if you don't want to wait.

Registered and logged in users are redirected immediately, why not consider signing up? It's free!